Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Sterol Carrier Protein 2 (SCP2) (N-Term) Peptid

SCP2 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN2182307

Kurzübersicht für Sterol Carrier Protein 2 (SCP2) (N-Term) Peptid (ABIN2182307)

Target

SCP2 (Sterol Carrier Protein 2 (SCP2))

Spezies

Human

Quelle

  • 5
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequenz

    SSPWEPATLR RVFVVGVGMT KFVKPGAENS RDYPDLAEEA GKKALADAQI

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-SCP2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeat freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    SCP2 (Sterol Carrier Protein 2 (SCP2))

    Hintergrund

    SCP2 protein is thought to be an intracellular lipid transfer protein. SCP2 is highly expressed in organs involved in lipid metabolism, and may play a role in Zellweger syndrome, in which cells are deficient in peroxisomes and have impaired bile acid synthesis.

    Alias Symbols: NLTP, NSL-TP, SCP-2, SCP-CHI, SCP-X, SCPX

    Protein Size: 503

    Molekulargewicht

    55 kDa

    Gen-ID

    6342

    NCBI Accession

    NM_001193600, NP_001180529

    UniProt

    A6NM69
Sie sind hier:
Chat with us!